Creative Medical Technology Announces Progress in Developing a Reproducible Clinical Grade of the Company’s ImmCelz® Product
PHOENIX, April 20, 2022 /PRNewswire/ — Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced progress in developing a reproducible clinical grade product of ImmCelz®. Multiple clinical experiments were performed in which […]
bit.bio’s Game-Changing Technology for Reprogramming Stem Cells
In this episode of Vital Science, Mark Kotter and his team at bit.bio have an innovative solution to help create consistent and scalable human cells to help researchers study diseases – by “reprogramming” stem cells. Video Transcription: – [Mark Kotter] What’s unique about bit.bio, is not really the use of these pluripotent stem cells, it’s […]
BioRestorative Therapies Announces Selection of 10 Clinical Sites for its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
MELVILLE, N.Y.,, April 18, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, today announced that it has selected 10 of its 15 clinical sites for its Phase 2 clinical trial targeting chronic lumbar disc disease. BioRestorative’s Phase 2 trial is a […]
Micro-Scaffolds Help Produce New Tissue From Stem Cells Faster
One of the most exciting and recent advances in tissue engineering and regenerative medicine (TERM) is to combine together multiple micro-size cellularized units, which are able to self-assemble altogether to recreate larger tissue constructs. A team of researchers at Vienna University of Technology have developed a new technique of creating buckyball shaped microscaffolds with a […]
ExCellThera announces new publication showing its ECT-001 cell therapy improves transplant access for all patients
MONTREAL, April 13, 2022 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), an advanced clinical-stage biotechnology company delivering molecules and bioengineering solutions to expand and engineer various cell lines for use in next generation cell and gene therapies, announced today the publication of a scientific article entitled “UM171 expansion of cord blood improves donor availability and HLA […]
Notch Therapeutics Welcomes Deepika Rajesh as VP, Stem Cell Biology & Developmental Immunology
VANCOUVER, BC , April 6, 2022 /PRNewswire/ — Notch Therapeutics, Inc., a biotechnology company developing renewable, induced pluripotent stem cell (iPSC)-derived cell therapies for cancer, is pleased to announce the appointment of Deepika Rajesh as VP, Stem Cell Biology and Developmental Immunology. Dr. Rajesh joins Notch from FUJIFILM Cellular Dynamics, Inc. (FCDI), where she was most […]
Global Stem Cell Group Launches New Lyophilized Exosomes Product
MIAMI LAKES, Fla., April 4, 2022 /PRNewswire/ — Global Stem Cells Group (GSCG) is proud to announce the launch of its new product with new lyophilized exosome technology. Global Stem Cells Group’s new product line includes innovative anti-aging products that can regenerate cells and tissues in the body. The new product, known as Cellgenic Lyophilized […]
Seattle Doctor Sued for Marketing Unproven Stem Cell Treatments
A concerned Washingtonian reported US Stemology’s claims to the Attorney General’s Office that it could treat and prevent COVID-19. Apparently the company made these claims for at least three months in the early stages of the pandemic. The Attorney General’s Office sent a cease and desist letter to US Stemology which made them remove the […]